Longitudinal analysis of the depressive effects of intravenous amiodarone on depolarization and repolarization: a case report

Journal of cardiology
Koichiro YoshiokaTeruhisa Tanabe

Abstract

Intravenous amiodarone (AMD) induces multiple antiarrhythmic effects via blocking of Na(+), Ca(2+), and IKr channels, and beta receptors. A patient on chronic dialysis was administered AMD for nonsustained ventricular tachycardia after successful cardiopulmonary resuscitation. QT prolongation occurred 5 h after AMD administration. AMD was withdrawn at 24 h because of prolonged QTc interval (716 ms), which persisted for a further 48 h (661 ms). Ventricular premature contraction (VPC) was significantly decreased at 7h; however, VPC increased again after discontinuing AMD. Depolarization changes induced by the Na(+)-channel blocking action of AMD were analyzed. There was increasing filtered QRS-duration and duration of low-amplitude signals at voltage <40 µV, and decreasing root-mean-square voltage of signals in the last 40 ms of ventricular late potentials (LPs) within 7 h. However after stopping AMD, LPs were reversed. The blood concentration of AMD reached the effective level within 10 min but decreased immediately to an ineffective level. Onset and disappearance of the VPC-inhibiting effect corresponded to the depressive effect on depolarization but not with the increase in the prolonged repolarization effect and blood concent...Continue Reading

References

Apr 14, 1983·The New England Journal of Medicine·M BonatiG Tognoni
Apr 1, 1983·Journal of Toxicology. Clinical Toxicology·M BonatiG Tognoni
Feb 1, 1996·Journal of Clinical Pharmacology·M R UjhelyiM S Chow
Nov 24, 1999·The American Journal of Cardiology·I KodamaJ Toyama
Mar 22, 2002·The New England Journal of Medicine·Paul DorianAiala Barr
Jul 24, 2004·Pacing and Clinical Electrophysiology : PACE·Takeshi AibaShiro Kamakura

❮ Previous
Next ❯

Citations

Feb 17, 2021·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Luigi Di BiaseAndrea Natale

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.